PUNE, India, September 12, 2016 /PRNewswire/ -- The global defibrillators market is forecast to reach $14.21 billion by 2021 from $10.01 billion in 2016 at a CAGR of 7.3% driven by the development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, rising incidences of cardiovascular diseases across the globe and growing focus of key market players toward public access defibrillation.

Complete report on global defibrillators market spread across 161 pages, profiling 10 companies and supported with 84 tables and 36 figures is now available at http://www.reportsnreports.com/reports/344031-defibrillators-market-by-product-implantable-cardioverter-defibrillator-single-dual-chamber-crt-d-s-icd-and-external-monitor-defibrillator-aed-wearable-by-end-user-hospital-pre-hospital-public-access-home-global-forecast-to-2019.html .

Geographically, the report covers four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global defibrillators market in 2016, followed by Europe. The Asia-Pacific defibrillators market is projected to witness the highest growth rate during the forecast period from 2016 to 2021 due to a number of factors, including improving healthcare infrastructure, favorable government initiatives, and growing focus of market players on the Asia-Pacific defibrillators market.
As of 2015, the global defibrillators market was dominated by Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands), and ZOLL Medical Corporation (U.S.), which together held a share of ~90% of the overall defibrillators market. The defibrillators market is broadly segmented into products and end users. By products, the defibrillators market is segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The external defibrillators segment is categorized into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The AEDs segment is further divided into semi-automated external defibrillators and fully automated external defibrillators. The ICDs segment is expected to account for the largest share of the global defibrillators market in 2016. However, automated external defibrillators segment is projected to grow at the highest CAGR during the forecast period due to a number of new product launches, increasing prevalence of cardiovascular diseases, rising government initiatives, and growing number of public access defibrillation programs.

Cardiology Homepage